ABSTRACT
Camels are the most adapted species to the harsh ecosystems of the African continent where they represent 80% of world's population. However, they can be susceptible to many pathogens such as Trypanosoma evansi. This parasite is widely distributed in Africa and represents a real threat to animal health and production. In Tunisia, despite its importance, this disease is underestimated and only a few data are available. The present study aims to investigate the prevalence of the disease by combining microscopic and serological tests. A cross-sectional study was conducted on 307 dromedary camels randomly selected from Southern Tunisia. Collected blood samples were microscopically examined and tested with Card Agglutination Trypanosomiasis Test to detect anti-T. evansi antibodies. The microscopic and serological prevalence were estimated at 2.93 and 62.54%, respectively. Microscopic examination showed morphological features of T. evansi. All positives samples were collected from aged males (>5 years old). Seroprevalence was similar for both sexes but it was higher in dry season and in the southwest of Tunisia. The present study revealed high prevalence of T. evansi infection among dromedary camels. This highlights the need for adequate control measures based on the detection and treatment of infected animals and vector control. We recommend investigating the prevalence of infection in other domestic animals living in the same environment.
Subject(s)
Camelus , Trypanosoma , Animals , Camelus/parasitology , Cross-Sectional Studies , Ecosystem , Female , Male , Seroepidemiologic StudiesABSTRACT
Blood glucose measurement is one of the most commonly performed clinical diagnostic tests used to monitor glycaemia in several animal diseases. Usually, these laboratory analyses are performed on blood venous samples in remote laboratories, and the results are delayed, at best. The use of portable glucometers could evidently solve many constraints but veterinary-use glucometers are not usually available. The present study aimed to compare blood glucose levels obtained by Bionime glucometer to the reference method using glucose oxidase. Venous blood was collected from a total number of 140 healthy dogs (72 males and 68 females), of different breeds (28 German Shepherd, 27 Pitt bull, 21 Boxer, 24 Rottweiler and 40 cross-bred dogs) and different ages (range: 3 months-14 years) for glucose measurement using the reference laboratory method. Capillary blood samples were used to conduct a glucose measurement with a human-use glucometer. Our results revealed that there was no significant difference between the mean capillary blood glucose (CBG) measured with the human-use glucometer (5.06 ± 0.84 mmol/L) and the mean venous blood glucose (VBG) measured with the laboratory reference method (4.90 ± 0.73 mmol/L) (p = 0.42). Similarly, there was no significant difference of the mean CBG and VBG in male dogs (5.11 ± 0.88 and 4.97 ± 0.75 mmol/L, respectively) and female dogs (5.01 ± 0.81 and 5.07 ± 0.72 mmol/L, respectively) (p = 0.73 and 0.21, respectively), and no correlation to neither age (5.43 ± 0.90 and 5.20 ± 0.70 mmol/L in 3 to 6 month-old dogs, 5.03 ± 0.82 and 4.94 ± 0.79 mmol/L in 6 months to 1 year-old, 4.94 ± 0.67 and 5.13 ± 0.66 mmol/L in 1 to 4 year-old dogs; 4.88 ± 0.94 and 4.80 ± 0.75 mmol/L in dogs older than 4 years, respectively, p < 0.05), nor to breed (4.94 ± 1.01 and 4.99 ± 0.79 mmol/L in German Shepherd, 5.13 ± 0.84 and 4.99 ± 0.79 mmol/L in Pitt Bull, 5.07 ± 0.94 and 5.07 ± 0.77 mmol/L in Boxer, 5.40 ± 0.59 and 5.48 ± 0.55 mmol/L in Rottweiler and 4.89 ± 0.75 and 4.77 ± 0.59 mmol/L in cross-bred dogs, respectively, p < 0.05). The present study confirms that human glucometer can be used to measure glucose in dogs with a good accuracy.
